Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood and Marrow Transplant (BMT)”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Large-scale testing (Phase 3)UnknownNCT02270307
What this trial is testing

MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis

Who this might be right for
LeukemiaMultiple Myeloma
National Research Center for Hematology, Russia 40
Testing effectiveness (Phase 2)Study completedNCT00427765
What this trial is testing

Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma
M.D. Anderson Cancer Center 168
Early research (Phase 1)Looking for participantsNCT05473910
What this trial is testing

T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
AMLMDS
TScan Therapeutics, Inc. 310
Testing effectiveness (Phase 2)Study completedNCT00506922
What this trial is testing

Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 150
Testing effectiveness (Phase 2)Study completedNCT01860170
What this trial is testing

Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

Who this might be right for
Hematological Malignancy
Corewell Health West 28
Not applicableStudy completedNCT01758042
What this trial is testing

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

Who this might be right for
Chronic Kidney DiseaseAcute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)+14 more
Massachusetts General Hospital 10
Large-scale testing (Phase 3)Study completedNCT04368559
What this trial is testing

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

Who this might be right for
CandidemiaMycosesFungal Infection+7 more
Mundipharma Research Limited 602
Not applicableStudy completedNCT00579917
What this trial is testing

Behavioral Intervention For BMT/SCT Survivors

Who this might be right for
Hodgkin's DiseaseLeukemiaMultiple Myeloma+1 more
Memorial Sloan Kettering Cancer Center 133
Large-scale testing (Phase 3)Study completedNCT01020175
What this trial is testing

Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation

Who this might be right for
Acute LeukemiaChronic Myelogenous LeukemiaMyelodysplastic Syndrome
European Society for Blood and Marrow Transplantation 350
Early research (Phase 1)Study completedNCT02660281
What this trial is testing

URMC Related Haplo-identical Donor BMT

Who this might be right for
Hematological DiseaseImmune DeficienciesSolid Tumors+3 more
University of Rochester 74
Testing effectiveness (Phase 2)Study completedNCT00186381
What this trial is testing

Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission

Who this might be right for
Leukemia, Myelocytic, AcuteLeukemiaBlood and Marrow Transplant (BMT)
Stanford University 200
Testing effectiveness (Phase 2)Study completedNCT00849147
What this trial is testing

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more
Medical College of Wisconsin 55
Early research (Phase 1)Study completedNCT00854139
What this trial is testing

Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)

Who this might be right for
Multiple MyelomaEnd Stage Renal Disease
Massachusetts General Hospital 10
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Testing effectiveness (Phase 2)Ended earlyNCT02127892
What this trial is testing

SCID Bu/Flu/ATG Study With T Cell Depletion

Who this might be right for
Severe Combined Immunodeficiency
Neena Kapoor, M.D. 9
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Testing effectiveness (Phase 2)Study completedNCT00809276
What this trial is testing

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Who this might be right for
LymphomaMultiple MyelomaLeukemia+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 92
Not applicableStudy completedNCT00186576
What this trial is testing

Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders

Who this might be right for
Myelodysplastic SyndromesMyeloproliferative DisordersBlood and Marrow Transplant (BMT)+2 more
Stanford University 40
Testing effectiveness (Phase 2)Study completedNCT00186394
What this trial is testing

High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinBlood and Marrow Transplant (BMT)Lymphomas: Non-Hodgkin
Stanford University 35
Testing effectiveness (Phase 2)Ended earlyNCT00589602
What this trial is testing

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 13
Next Page